Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease
- 23 September 2023
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 119 (6) , 1197-1200
Abstract
INTRODUCTION: Limited data exist evaluating antiobesity medications (AOM) in patients with inflammatory bowel disease (IBD). METHODS: We performed a case-control study evaluating the effectiveness and safety of AOM in patients with IBD with obesity, matched to non-IBD controls. RESULTS: After 12 months, the case (n = 36) and control (n = 36) groups achieved similar percent total body weight loss of −6.9 ± 8.3 and −8.1 ± 7.0 (P = 0.30), respectively. Side effect profiles were similar between groups. Seven patients experienced an IBD flare, all managed medically. DISCUSSION: AOM use in patients with IBD demonstrated similar effectiveness and safety when compared with that observed in the non-IBD population.Keywords
This publication has 14 references indexed in Scilit:
- Effects of obesity on the course of inflammatory bowel diseaseBaylor University Medical Center Proceedings, 2019
- Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2004–2014Obesity Surgery, 2017
- Bariatric Surgery Is Acceptably Safe in Obese Inflammatory Bowel Disease Patients: Analysis of the Nationwide Inpatient SampleObesity Surgery, 2017
- The Impact of Obesity on the Clinical Course of Inflammatory Bowel Disease: A Meta-AnalysisMedical Science Monitor, 2017
- Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomesNature Reviews Gastroenterology & Hepatology, 2016
- Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trialsDiabetes, Obesity and Metabolism, 2016
- Outcomes of Bariatric Surgery in Patients with Inflammatory Bowel DiseaseObesity Surgery, 2015
- Erratum: Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized studyInternational Journal of Obesity, 2014
- Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2014
- Possible association of ischemic stroke with phentermine.Stroke, 1993